Fulltext
This part is available in the PDF file.
International Journal of Endocrinology and Metabolism
Research Institute for Endocrine Sciences
Outlines
Pharmacotherapy Of Type 2 Diabetes – The Future
Author(s):
1Department of Pharmacology, Osmania Medical College, Hyderabad – 500 095, India
Published online:Jan 31, 2006
Article type:Research Article
Received:May 28, 2019
Accepted:Jan 31, 2006
How to Cite:Abhay A, Ravichand D, Seshayamma V, Satish chandran P. Pharmacotherapy Of Type 2 Diabetes – The Future. Int J Endocrinol Metab. 2006;4(3):e94594. doi:
Abstract
Keywords
References
- 1.The references are available in the PDF file.
Copyright
© 2006, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Similar Articles
20
Nov
2017
Pharmacological Treatment in Diabetes Mellitus Type 1 – Insulin and What Else?
Ewa Otto-Buczkowska,
Natalia Jainta
Otto-Buczkowska E, Jainta N. Pharmacological Treatment in Diabetes Mellitus Type 1 – Insulin and What Else?. Int J Endocrinol Metab. 2018;16(1):e13008. doi: https://doi.org/10.5812/ijem.13008
1
Jul
2013
Role of Insulin in the Type 2 Diabetes Therapy: Past, Present and Future
Carlo Maria Rotella,
Laura Pala,
Edoardo Mannucci
Maria Rotella C, Pala L, Mannucci E. Role of Insulin in the Type 2 Diabetes Therapy: Past, Present and Future. Int J Endocrinol Metab. 2013;11(3):137-144. doi: https://doi.org/10.5812/ijem.7551
21
Apr
2018
Insulin Monotherapy Versus Insulin Combined with Other Glucose-Lowering Agents in Type 2 Diabetes: A Narrative Review
Hengameh Abdi,
Fereidoun Azizi,
Atieh Amouzegar
Abdi H, Azizi F, Amouzegar A. Insulin Monotherapy Versus Insulin Combined with Other Glucose-Lowering Agents in Type 2 Diabetes: A Narrative Review. Int J Endocrinol Metab. 2018;16(2):e65600. doi: https://doi.org/10.5812/ijem.65600
31
Jan
2008
Achieving Glycaemic Targets in Type 2 Diabetes: the Role of the Basal Insulin Analogue Insulin Glargine and How to Use it in Clinical Practice: Moving from Evidence to Practice
MJ Davies,
J Jarvis,
K Khunti
Davies M, Jarvis J, Khunti K. Achieving Glycaemic Targets in Type 2 Diabetes: the Role of the Basal Insulin Analogue Insulin Glargine and How to Use it in Clinical Practice: Moving from Evidence to Practice. Int J Endocrinol Metab. 2008;6(1):. doi:
14
Mar
2005
Outcome of reinitiation of combination anti diabetic oral therapy in insulin treated patients with Type 2 Diabetes Mellitus
M Afkhami-ardekani,
HR Jafaryzadeh
Afkhami-ardekani M, Jafaryzadeh H. Outcome of reinitiation of combination anti diabetic oral therapy in insulin treated patients with Type 2 Diabetes Mellitus. Zahedan J Res Med Sci. 2005;7(1):e94976. doi:
Comments
Number of Comments:0Cited by
- Scopus by DOI: 0
Last Update: 1 week ago
- Scopus by Title: 0
Last Update: 1 week ago
- Scopus by Title (Ref): 0
Last Update: 1 week ago
- CrossRef: 0
Last Update: 2 days ago
Ordering Reprints
Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC
Search Relations
Author(s):
Related Articles